News

Metamorphx is emerging as a leading natural GLP-1 alternative for weight loss in 2025. With prescription options like ...
A large study in older adults with type 2 diabetes finds that GLP-1 receptor agonists are associated with a modestly ...
Today, Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) submission for an investigational once-daily, 25 mg oral formulation of Wegovy® ...
Scientists have discovered a gut microbe and its metabolites that can naturally regulate blood sugar levels and sugar ...
Eli Lilly and Company (NYSE: LLY) today announced its financial results for the first-quarter of 2025.
Hollywood celebrities using popular weight loss drug Ozempic to shred those unwanted pounds are now facing an unexpected new side effect dubbed “Ozempic mouth,” according to a report.
SHOPPING: If you're ready to meet your weight goals, turn to Hims for personalized weight loss treatments that are ...
The Trump administration this April scrapped a Biden-era proposal that would have required state Medicaid programs and allowed federal Medicare to pay for some GLP-1s for obesity treatment. Instead, ...
Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine.
More than 2.5 billion adults worldwide are currently overweight or obese, according to estimates from the World Health Organization.
Kyle Richards ' 25-year-old daughter Sophia Umansky has shared a "graphic" video of the extensive hair loss she has suffered after taking a weight loss drug for four months.